TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising step toward Epstein-Barr therapeutics. Hosts: Vincent Racaniello, Rich Condit, Brianne Barker, and Jolene Ramsey Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Dolly Parton, and advocate for science (Nature) Phage bet-hedging (Nat Micro) EBV monoclonal antibodies (Cell Rep Med) Letters read on TWiV 1353 Timestamps by Jolene Ramsey. Thanks! Picks of the Week Brianne – Did life on Earth emerge once or twice? Rich – Cassini Approaches Saturn (Wiki on Cassini) Jolene – Dolly Parton's rewrite of Jolene song for vaccines on CBS news (Youtube) Vincent – Thinking, Fast and Slow by Daniel Kahneman Listener Pick John – Dolly Parton Sings Vaccine, Vaccine Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from This Week in Virology
TWiV 1359: SSPE, the Long Shadow of Measles
TWiV 1358: Clinical Update with Dr. Daniel Griffin
TWiV 1357: Furin, Naturally with Paul Bieinasz
TWiV 1356: Clinical update with Dr. Daniel Griffin
Get summaries like this every morning.
Free AI-powered recaps of This Week in Virology and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.